Abstract Library
Members may log into MY ENETS to visit the abstract library from previous ENETS conferences.
Participants of the ENETS Conference in 2024 can now access the abstract booklet, e-posters and videos, slide decks of talks, the poster carousel, and more via My ENETS.
ENETS Abstract Search
Introduction: The possible impact of octreotide (OCT) Long-Acting Release (LAR) on the immune system regulation is largely unexplored.
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author:
Authors: Ottaiano A, Rea G, Capozzi M, Napolitano M, Tatangelo F,
Keywords: Octreotide, Tregs, MDSCs, immune system,
Introduction: Therapy-related myeloid neoplasm (t-MN) has been reported as a potential long-term and frequently lethal adverse event after PRRT in NET. However, the incidence, time of diagnosis, and nature of t-MN is unclear.
Conference: 17th Annual ENETSConcerence (2020)
Presenting Author: Sonbol M
Authors: Sonbol M, Hilal T, Halfdanarson T,
Keywords: PRRT, t-MN, therapy-related myeloid neoplasm, leukemia, NET, MDS,
Introduction: SSAs are used in the treatment of G1/G2 Neuroendocrine Neoplasms (NEN) in order to control symptoms and induce tumor shrinkage with an excellent tolerability profile. The role of immune response is crucial in defining the clinical response to treatment through the active stimulation of effector cells (T and NK cells) but also through the inhibition of tumor-induced immune suppression. The immune regulatory cells CD4-CD25-expressing Tregs and myeloid cellsMDSC can contribute to disease progression through various mechanisms.
Conference: 15th Annual ENETSConcerence (2018)
Presenting Author:
Authors: Napolitano M, De Divitiis C, Santagata S, Capozzi M, Ottaiano A,
Keywords: neuroendocrine tumors, somatostatin analogs, immune regulatory cells, Tregs MDSC, Immunotherapy,